Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

The FreeStyle Libre 3 Continuous Glucose Monitoring System is intended to monitor glucose levels continuously. It helps people manage diabetes by detecting trends and tracking patterns in glucose ...

Lingo is based on Abbott's world-leading FreeStyle Libre® continuous glucose monitoring technology 1, now used by more than 6 million people with diabetes globally 1. "There is a great deal of ...

Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes ...

Abbott launched an over-the-counter continuous glucose monitoring system, Lingo, for adults not on insulin -- the second such ...

Also Read: Dexcom’s Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients. This recall involves removing certain devices from where they are used or sold and does ...

Abbott (NYSE: ABT) today announced U.S. availability of Lingo™, the company's first continuous glucose monitoring system available without a prescription. The Lingo system includes a biosensor and a ...

Abbott has announced the U.S. availability of Lingo, the company’s first glucose monitoring system available without ...